Journal: Regenerative Therapy
Article Title: Modified bFGF targeting connective tissue growth factor in the injured microenvironment improved cardiac repair after chronic myocardial ischemia
doi: 10.1016/j.reth.2025.01.006
Figure Lengend Snippet: The administration of CFBP-bFGF can alleviate MI-induced cardiac fibrosis and alleviate adverse cardiac remodeling . (A) Immunofluorescence staining and statistical analysis of collagenⅠ; (B) Immunofluorescence staining and statistical analysis of Vimentin; (C)Western blot results of TGF-β pathway and Smad7, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, n = 6.
Article Snippet: The antigen sites were blocked by 5 % skim milk powder, incubated at room temperature for 1∼2h, and incubated at 4 °C in the corresponding primary antibody overnight: Anti-FGF-2 Rabbit pAb (1:1000, BS6432, Bioworld), Anti-CTGF (1:1000, BS-0743R, Bioss), Anti-Smad7 Rabbit pAb(1:1000, 860746, zenbio), Anti-TGF beta 1 Rabbit mAb(1:1000, HUABIO, HA721143), Anti-Smad3(1:2000, Abcam, ab40854), Anti-p-Smad3 Rabbit mAb(1:1000, zenbio, R22919), Anti-β-actin Rabbit pAb (1:10,000, AP0060, Bioworld), Anti-GAPDH Rabbit pAb (1:10,000, AP0066, Bioworld).
Techniques: Immunofluorescence, Staining, Western Blot